Hjem › Endometriekreft › Alaska
Kliniske studier for Endometriekreft i Alaska
4 studier for Endometriekreft søker deltakere på steder i Alaska.
Byer i Alaska
Offisiell studietekst (engelsk)
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
- Alaska Women's Cancer Care, Anchorage
RekruttererFase 3
Alder 18 og eldre · Kvinner · Oppdatert 5. okt. 2026 · NCT07198074Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- Alaska Women's Cancer Care, Anchorage
RekruttererFase 2
Alle aldre · Alle kjønn · Oppdatert 5. okt. 2026 · NCT05564377Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
- Alaska Womens Cancer Care, Anchorage
RekruttererFase 2
Alder 18 og eldre · Kvinner · Oppdatert 24. sep. 2026 · NCT05640999A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
- Alaska Women's Cancer Care ( Site 6036), Anchorage
RekruttererFase 3
Alder 18 og eldre · Kvinner · Oppdatert 17. sep. 2026 · NCT06952504Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.